Cited by — Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer.
No admitted local citation edges point to this work yet.
